WallStreetZenWallStreetZen

NASDAQ: MRNS
Marinus Pharmaceuticals Inc Stock Ownership - Who owns Marinus Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Marinus Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Martha E. ManningSVP GEN. COUNSEL CORP. SEC.2024-08-053,621$1.13
$4.09kSell
Scott BraunsteinCHAIRMAN AND CEO2024-08-0512,145$1.13
$13.72kSell
Christina ShaferCHIEF COMMERCIAL OFFICER2024-08-053,820$1.14
$4.35kSell
Joseph HulihanCHIEF MEDICAL OFFICER2024-08-054,828$1.13
$5.46kSell
Steven PfanstielCFO AND COO2024-08-054,657$1.13
$5.26kSell
Scott BraunsteinCHAIRMAN AND CEO2024-03-2750,000$4.28
$214.00kBuy
Martha E. ManningSVP GEN. COUNSEL CORP. SEC.2024-02-201,894$9.57
$18.13kSell
Christina ShaferCHIEF COMMERCIAL OFFICER2024-02-202,153$9.56
$20.58kSell
Scott BraunsteinCHAIRMAN AND CEO2024-02-1611,850$9.94
$117.79kSell
Joseph HulihanCHIEF MEDICAL OFFICER2024-02-162,814$9.98
$28.08kSell

1 of 2

MRNS insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MRNS insiders and whales buy or sell their stock.

MRNS Shareholders

What type of owners hold Marinus Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Suvretta Capital Management LLC9.19%5,073,913$1.39MInstitution
Franklin Resources Inc8.54%4,713,014$1.29MInstitution
Tang Capital Management LLC8.52%4,700,000$1.29MInstitution
Sofinnova Investments Inc7.95%4,386,177$1.20MInstitution
Bain Capital Life Sciences Investors LLC7.21%3,977,453$1.09MInsider
Vanguard Group Inc5.08%2,802,965$768.01kInstitution
Bain Capital Life Sciences Investors LLC4.88%2,693,380$737.99kInstitution
Abrdn PLC4.82%2,658,527$728.44kInstitution
Stephen M. Bloch4.53%2,500,948$685.26kInsider
Domain Partners VI LP4.49%2,476,886$678.67kInsider

1 of 3

MRNS vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MRNS74.95%21.62%Net Selling
CRVO4.87%95.13%Net Buying
NERV5.99%94.01%
NRSN1.25%0.00%
TRAW2.34%97.66%Net Selling
View Top Biotech Stocks

Marinus Pharmaceuticals Stock Ownership FAQ

Who owns Marinus Pharmaceuticals?

Marinus Pharmaceuticals (NASDAQ: MRNS) is owned by 74.95% institutional shareholders, 21.62% Marinus Pharmaceuticals insiders, and 3.42% retail investors. Bain Capital Life Sciences Investors LLC is the largest individual Marinus Pharmaceuticals shareholder, owning 3.98M shares representing 7.21% of the company. Bain Capital Life Sciences Investors LLC's Marinus Pharmaceuticals shares are currently valued at $1.14M.

If you're new to stock investing, here's how to buy Marinus Pharmaceuticals stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.